Here’s the press release. It’s all dressed up as science with words like, profiles, signature, carefully formulated but they give it away in their opening gambit
This collaboration marks a new era for full-branded portfolios
Brands and $’s etc etc
Here’s the release
Cookies, the most globally recognised cannabis brand, is entering global medical markets with a full extract portfolio through a strategic partnership with SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO).
This collaboration marks a new era for full-branded portfolios of medicinal cannabis products with Cookies’ signature terpene and flavonoid profiles, the foundation of its world-renowned flower reputation, are now refined, standardised, and transformed into pharmaceutical-grade extracts under SOMAÍ’s precise EU-GMP manufacturing standards.
Defining Taste — From Culture to Science
Cookies has long been celebrated for its iconic and evolving flower genetics — a brand built on flavour, experience, and culture. SOMAÍ now bridges that legacy with pharmaceutical innovation, transforming Cookies’ distinctive terpene and flavonoid profiles into highly standardised medical extracts.
These carefully formulated oral and inhalation products preserve the full sensory experience of Cookies’ strains— its recognisable aroma, flavour, and entourage profile — while meeting the highest standards of safety, stability, and purity.
“At SOMAÍ, we believe that taste isn’t just an experience — it’s a part of how patients connect with their medicine,” said Michael Sassano, Founder and Interim CEO of SOMAÍ. “Bringing Cookies’ iconic terpene blends into the medical space allows us to merge culture with compliance and deliver products that patients trust, enjoy, and truly benefit from.”
